138 related articles for article (PubMed ID: 1773000)
1. Production of thromboxane and prostaglandins in human blood in the presence of thromboxane synthase inhibitors: a comparison of RIA and GC/MS determinations.
Weber C; Beetens JR; Van de Wiele R; Höller M; De Clerck F
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):7-15. PubMed ID: 1773000
[TBL] [Abstract][Full Text] [Related]
2. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
[TBL] [Abstract][Full Text] [Related]
3. Comparison of radioimmunoassay and high-resolution gas chromatography mass spectrometry for the quantitative determination of serum thromboxane B2 and 6-keto-PGF1 alpha after pharmacological blockade of thromboxane synthetase.
Chiabrando C; Castagnoli MN; Noseda A; Fanelli R; Rajtar G; Cerletti C; de Gaetano G
Prostaglandins Leukot Med; 1984 Oct; 16(1):79-88. PubMed ID: 6440153
[TBL] [Abstract][Full Text] [Related]
4. Determination of 6-keto-PGF1 alpha, TXB2, PGF2 alpha, PGE2, PGD2 in human blood: a comparison of RIA and GC-NICI-MS.
Weber C; Beetens J; van de Wiele R; Beile A; Lohkamp R; de Clerck F; Höller M
Prog Clin Biol Res; 1989; 301():113-7. PubMed ID: 2798442
[No Abstract] [Full Text] [Related]
5. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
6. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation.
Asbóth G; Gimes G; Hertelendy F; Tóth M
Biochim Biophys Acta; 1989 Mar; 1002(1):101-8. PubMed ID: 2493805
[TBL] [Abstract][Full Text] [Related]
7. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin synthesis by the cochlea.
Kawata R; Urade Y; Tachibana M; Mizukoshi O
Prostaglandins; 1988 Feb; 35(2):173-84. PubMed ID: 3129756
[TBL] [Abstract][Full Text] [Related]
9. In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Maguire ED; Wallis RB
Thromb Res; 1983 Oct; 32(1):15-27. PubMed ID: 6689221
[TBL] [Abstract][Full Text] [Related]
10. Validation of the direct radioimmunoassay of prostanoids in serum and kidney.
Codde JP; Barden A; Vandongen R; Beilin LJ
Prostaglandins Leukot Med; 1984 Apr; 14(1):55-64. PubMed ID: 6587406
[TBL] [Abstract][Full Text] [Related]
11. Placental biosynthesis and metabolism of prostanoids: special reference to guinea-pig during the last third of gestation.
Moussard C; Alber D; Remy-Martin JP; Henry JC
Prostaglandins Leukot Med; 1986 Jan; 21(1):37-49. PubMed ID: 3456619
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry.
Schweer H; Kammer J; Seyberth HW
J Chromatogr; 1985 Mar; 338(2):273-80. PubMed ID: 3858280
[TBL] [Abstract][Full Text] [Related]
13. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry.
Schweer H; Watzer B; Seyberth HW
J Chromatogr; 1994 Feb; 652(2):221-7. PubMed ID: 8006107
[TBL] [Abstract][Full Text] [Related]
14. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron.
Farman N; Pradelles P; Bonvalet JP
Am J Physiol; 1987 Jan; 252(1 Pt 2):F53-9. PubMed ID: 3101513
[TBL] [Abstract][Full Text] [Related]
15. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
17. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
Ritter JM
Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
[TBL] [Abstract][Full Text] [Related]
18. Ridogrel, a combined thromboxane synthase inhibitor and receptor blocker, decreases elevated plasma beta-thromboglobulin levels in patients with documented peripheral arterial disease.
Hoet B; Arnout J; Van Geet C; Deckmyn H; Verhaeghe R; Vermylen J
Thromb Haemost; 1990 Aug; 64(1):87-90. PubMed ID: 2148849
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy.
Jouve R; Rolland PH; Delboy C; Mercier C
Am Heart J; 1984 Jan; 107(1):45-52. PubMed ID: 6581715
[TBL] [Abstract][Full Text] [Related]
20. Placental transfer of the thromboxane synthetase inhibitor ridogrel in the late-pregnant ewe.
Schneider TJ; Struijk PC; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):83-7. PubMed ID: 10471147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
